We only have this paper's title and publication details.
Read it at the sourceRandomized trial compares clinical outcomes between nivolumab and bevacizumab in recurrent glioblastoma, highlighting therapeutic alternatives for progressive brain tumors.
ClinicalTrials.gov Identifier: NCT02017717.
No takes yet. Share an insight, caveat, or question.
Reardon et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: